MediView logo
  • Home
  • Technology
        • About Our TechDiscover our technology and how it works.
        • OmnifyXR®Customize workflow visualization, unlock greater potential of imaging, and facilitate enhanced ergonomics for procedures.
        • MediView XR90™Experience unprecedented 3D views of patient internal anatomy to plan and execute procedures with increased confidence.
  • About
        • About UsWe’re on a mission to advance healthcare delivery with intuitive visualization.
        • TeamMeet the great minds who are transforming diagnostic imaging, surgical navigation, and patient care.
        • Visionary EducationDiscover AR solutions to enhance learning and improve student outcomes.
        • CareersJoin us as we drive our vision forwards and learn more about open opportunities at MediView.
        • Authorized AgenciesLearn more about our sales partners.
  • In The News
  • Publications
  • Contact
Contact
Mediview Announces New Clinical Advisory Board Member (Francois)

Mediview Announces New Clinical Advisory Board Member (Francois)

MediView is pleased to announce the addition of Dr. François H. Cornelis as a new member to the MediView Clinical Advisory Board. Dr. Cornelis is an Attending Radiologist at Memorial Sloan Kettering Cancer Center and Professor of Radiology at Weill Cornell Medicine.

Dr. Cornelis is an accomplished interventional radiologist with a specialized focus in neurointerventional oncology and cancer imaging. His clinical expertise spans a wide range of procedures, including image-guided interventions for both adult and pediatric patients, with a particular emphasis on the treatment of abdominal, spine, bone, and soft tissue tumors through advanced techniques like percutaneous ablation. Dr. Cornelis has also been instrumental in developing and refining image-guided techniques for treating metastatic bone fractures and various neurointerventions for head and neck tumors.

“The MediView team is honored to welcome Dr. François Cornelis to our Clinical Advisory Board. His unparalleled expertise in interventional oncology and his groundbreaking work in image-guided therapies will be invaluable as we continue to innovate and push the boundaries of advanced visualization. Dr. Cornelis’ insights and leadership in translating cutting-edge research into clinical practice will undoubtedly elevate our efforts and drive our mission forward. We are confident that his contributions will add tremendous value to our team and help us make a lasting impact on patient care,” said Mina Fahim, MediView CEO and President.

Dr. Cornelis holds an extensive educational background, beginning with his medical degree from the University of Bordeaux in 2003, followed by an MS in Radiophysics from Université Toulouse III Paul Sabatier. He further advanced his expertise with a PhD in Applied Mathematics from the Institut de Mathématiques de Bordeaux and a DSC in Medicine from Université Pierre et Marie Curie, Sorbonne University. His postgraduate training includes residencies in radiology and interventional radiology at the University of Bordeaux, along with a research fellowship at the Sloan Kettering Institute in New York.

Throughout his career, Dr. Cornelis has received numerous accolades, including multiple Distinguished Reviewer Awards from the Journal of Vascular and Interventional Radiology and the Abdominal Radiology journal. He has also been honored with the Alavi-Mandell Award by the Society of Nuclear Medicine and Molecular Imaging and the ESUI Vision Award from the European Society of Urology. His research has led to the publication of several groundbreaking studies in advanced image-guided therapies, making him a key figure in the translation of innovative technologies into clinical practice.

Related posts:

Entrepreneurs ‘Xcelerate’ Innovation At Pitch Competition HoloLens To Assess The Resectability Of Ovarian Cancer MediView XR Receives Investment from JobsOhio Growth Capital Fund MediView TechnologyMediView XR, Inc. Secures $15M Strategic Funding Round with Backing from Leading Collaborators across Clinical, Industry and Government

Related posts:

MediView XR Receives Investment from JobsOhio Growth Capital Fund

Medivew, Transformational Augmented Reality Medtech Company, Secures $9.9 Million Safe Funding

Mediview Announces New Advisory Board Member (Mark)

Mediview announced as Grand Prize Winner of the 2022 CableLabs 10G Challenge

First in Education, Research, Innovation: New Partnership Brings MediView Augmented Reality Platform to Carle Illinois College of Medicine

Browse Topics

  • News
216-306-1977
info@mediview.com

Technology

  • About Our Tech
  • OmnifyXR
  • Mediview XR90

About

  • Careers
  • Visionary Education
  • Team
  • About Us
  • Authorized Agencies

Insights

  • In The News
  • Publications

© 2026 MediView XR, Inc. All Rights Reserved.

Privacy Policy | Terms of Service | Cookie Settings